Certican is an immunosuppressant used to prevent organ rejection after heart, liver, or kidney transplants. It contains everolimus, which inhibits the proliferation of immune cells responsible for attacking the transplanted organ, reducing the likelihood of rejection and helping stabilize the function of the new organ. It is an important part of the post-transplant treatment plan under close medical supervision.
This combination contributes to enhancing the chances of long-term success of the procedure, as Certican helps achieve a delicate immune balance and protects the patient from serious complications associated with organ rejection. It also supports health stability and reduces the risk of relapses. It is important to strictly adhere to the prescribed doses and conduct periodic tests to monitor drug levels in the blood, ensuring its effectiveness and avoiding side effects as much as possible.